The Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop vaccine candidates against unknown pathogenic threats with the particular development of saRNA vaccines that use the body’s own machinery to make antigenic protein.
